Given the potential pathophysiological connection between PD and inflammatory bowel disease (IBD), they evaluated the incidence of PD in IBD patients and investigated whether anti-tumor necrosis factor (anti-TNF) treatment for IBD affected the risk of developing PD. Here, TNF is linked to inflammatory bowel disease.